文献速递脑血管病外科

体积分期与剂量分期立体定向放射外科治疗大型脑动静脉畸形的疗效比较:一项系统综述

Volume-staged versus dose-staged stereotactic radiosurgery outcomes for large brain arteriovenous malformations: a systematic review.
PubMed 文献 · J Neurosurg · 2017-01-27

该系统综述通过PubMed检索比较体积分期(VS)与剂量分期(DS)立体定向放射外科(SRS)治疗大型(体积>10 cm3)脑动静脉畸形(AVM)的结局,纳入11项VS-SRS研究(299例)和10项DS-SRS研究(219例)。VS-SRS平均闭塞率为41.2%(95%CI 31.4%-50.9%),DS-SRS为32.3%(95%CI 15.9%-48.8%);VS-SRS似乎可获得更高闭塞率,但并发症情况较差。作者认为VS-SRS或DS-SRS可作为大型AVM的合理治疗选择,单独应用或作为多模式管理策略的组成部分。

要点

  • VS-SRS平均闭塞率41.2%(95%CI 31.4%-50.9%),DS-SRS为32.3%(95%CI 15.9%-48.8%)。
  • VS-SRS症状性放射性改变13.7%(44/322),DS-SRS为12.2%(31/254)。
  • VS-SRS SRS后出血19.5%(50/256),DS-SRS为10.6%(30/282)。

核心结论

  • 体积分期SRS似乎比剂量分期SRS获得更高的闭塞率,但并发症情况较差。
  • VS-SRS或DS-SRS可作为大型AVM的合理治疗选择,单独应用或作为多模式管理策略的组成部分。

研究设计与样本

  • 系统综述,通过PubMed检索纳入5例及以上接受VS-SRS或DS-SRS治疗的大型AVM(体积>10 cm3)患者队列。
  • 共纳入11项VS-SRS研究(299例合格患者)和10项DS-SRS研究(219例合格患者)。
  • 提取基线数据及SRS后结局进行分析。

主要发现

  • VS-SRS平均闭塞率为41.2%(95%CI 31.4%-50.9%),DS-SRS为32.3%(95%CI 15.9%-48.8%)。
  • 基于汇总个体患者数据,VS-SRS患者闭塞率为40.3%(110/273),症状性放射性改变为13.7%(44/322),SRS后出血为19.5%(50/256),死亡为7.4%(24/323)。
  • 基于汇总个体患者数据,DS-SRS患者闭塞率为32.7%(72/220),症状性放射性改变为12.2%(31/254),SRS后出血为10.6%(30/282),死亡为4.6%(13/281)。

临床怎么用

  • 作者认为VS-SRS或DS-SRS可作为大型AVM的合理治疗选择,单独应用或作为多模式管理策略的组成部分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Several recent studies have improved our understanding of the outcomes of volume-staged (VS) and dose-staged (DS) stereotactic radiosurgery (SRS) for the treatment of large (volume > 10 cm3) brain arteriovenous malformations (AVMs). In light of these recent additions to the literature, the aim of this systematic review is to provide an updated comparison of VS-SRS and DS-SRS for large AVMs. METHODS A systematic review of the literature was performed using PubMed to identify cohorts of 5 or more patients with large AVMs who had been treated with VS-SRS or DS-SRS. Baseline data and post-SRS outcomes were extracted for analysis. RESULTS A total of 11 VS-SRS and 10 DS-SRS studies comprising 299 and 219 eligible patients, respectively, were included for analysis. The mean obliteration rates for VS-SRS and DS-SRS were 41.2% (95% CI 31.4%-50.9%) and 32.3% (95% CI 15.9%-48.8%), respectively. Based on pooled individual patient data, the outcomes for patients treated with VS-SRS were obliteration in 40.3% (110/273), symptomatic radiation-induced changes (RICs) in 13.7% (44/322), post-SRS hemorrhage in 19.5% (50/256), and death in 7.4% (24/323); whereas the outcomes for patients treated with DS-SRS were obliteration in 32.7% (72/220), symptomatic RICs in 12.2% (31/254), post-SRS hemorrhage in 10.6% (30/282), and death in 4.6% (13/281). CONCLUSIONS Volume-staged SRS appears to afford higher obliteration rates than those achieved with DS-SRS, although with a less favorable complication profile. Therefore, VS-SRS or DS-SRS may be a reasonable treatment approach for large AVMs, either as stand-alone therapy or as a component of a multimodality management strategy.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ilyas A, Chen CJ, Ding D, et al. Volume-staged versus dose-staged stereotactic radiosurgery outcomes for large brain arteriovenous malformations: a systematic review. J Neurosurg. 2017. PMID: 28128692. doi:10.3171/2016.9.JNS161571

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。